Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Assessment of Total Lesion Glycolysis and Metabolic Tumor Volume Improve the Clinical Value of Focal Lesion Assessment By FDG PET/CT in Myeloma

James E McDonald, Marcus M Kessler, Michael Gardner, Amy Buros, PhD, Sarah Waheed, MD, James Ntambi, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Christoph Heuck, MD, Nathan Petty, MS, Carolina Schinke, MD, Sharmilan Thanendrarajan, MD, Alan Mitchell, Antje Hoering, Bart Barlogie, MD PhD, Gareth J Morgan, MD PhD, Faith E Davies, MD

Blood (2015) 126 (23): 724.

https://doi.org/10.1182/blood.V126.23.724.724

Published: 2015

Journal Articles

Re-Mineralization of Large Pelvic Lytic Lesions By CT Imaging in Patients with Multiple Myeloma: The Arkansas Experience

Meera Mohan, Rohan Samant, Larry J Suva, Corey O Montgomery, Daisy V. Alapat, MD, Roy Morello, Frits van Rhee, MD PhD, Sarah Waheed, MD, Sharmilan Thanendrarajan, MD, Carolina Schinke, MD, Christoph Heuck, MD, Yogesh Jethava, MD, Donald Johann, MD MS, Bart Barlogie, MD PhD, Faith E Davies, MD, Gareth J Morgan, MDPhD, Maurizio Zangari, MD

Blood (2015) 126 (23): 4193.

https://doi.org/10.1182/blood.V126.23.4193.4193

Published: 2015

Journal Articles

Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma

Sarah Waheed, MD, Hongwei Wang, Pingping Qu, PhD, Christoph Heuck, MD, Aasiya Matin, Yogesh Jethava, MB, MRCP, MD FRCPath, Frits van Rhee, MD PhD, Antje Hoering, Bart Barlogie, MD PhD, Faith E Davies, MD, Gareth J Morgan, MDPhD

Blood (2015) 126 (23): 1777.

https://doi.org/10.1182/blood.V126.23.1777.1777

Published: 2015

Journal Articles

Spectrum of Cerebrovascular Disease in Multiple Myeloma Patients Undergoing Chemotherapy

Archana Hinduja, MD, Kaustubh Limaye, MD, Rahul Ravilla, MD, Appalanaidu Sasapu, MD MS, Xenofon Papanikolaou, MD, Sarah Waheed, MD

Blood (2015) 126 (23): 5498.

https://doi.org/10.1182/blood.V126.23.5498.5498

Published: 2015

Journal Articles

Outcomes of Autologous Transplantation for Treatment-Related AML and MDS in Previously Treated Multiple Myeloma Patients (pts)

Shebli Atrash, Bart Barlogie, MD PhD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Sarah Waheed, MD, Clyde Bailey, Nathan Petty, MS, Christoph Heuck, MD, Gareth J Morgan, MDPhD, Yogesh Jethava, MD

Blood (2015) 126 (23): 1997.

https://doi.org/10.1182/blood.V126.23.1997.1997

Published: 2015

Journal Articles

A Prognostic 51-Gene Signature Linked to Abnormal Metaphase Cytogenetics Identifies Myeloma Patients Who Benefit from Fractionated Melphalan Dosing and Added Bortezomib, Thalidomide and Dexamethasone As Conditioning for Autologous Stem Cell Transplant

Blood (2015) 126 (23): 3181.

https://doi.org/10.1182/blood.V126.23.3181.3181

Published: 2015

Journal Articles

Defining the Impact of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma: A Case-Match Analysis in the Total Therapy Trials

Sharmilan Thanendrarajan, MD, Caleb K. Stein, MS, Faith E Davies, MD, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Christoph Heuck, MD, Carolina Schinke, MD, Sarah Waheed, MD, Yogesh Jethava, MB, MRCP, MD FRCPath, Niels Weinhold, PhD, Aasiya Matin, Pankaj Mathur, Meera Mohan, Muthukumar Radhakrishnan, Bart Barlogie, MD PhD, Gareth J Morgan, MDPhD

Blood (2015) 126 (23): 3182.

https://doi.org/10.1182/blood.V126.23.3182.3182

Published: 2015

Journal Articles

Comprehensive Genomic Profiling of Multiple Myeloma in the Course of Clinical Care Identifies Targetable and Prognostically Significant Genomic Alterations

Blood (2015) 126 (23): 369.

https://doi.org/10.1182/blood.V126.23.369.369

Published: 2015

Journal Articles

The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM

Blood (2015) 126 (23): 372.

https://doi.org/10.1182/blood.V126.23.372.372

Published: 2015

Journal Articles

Waldenstrom's Macroglobulinemia Associated Bone Disease the UAMS Experience

Xenofon Papanikolaou, MD, Sarah Waheed, MD, Bart Barlogie, MD PhD, Daisy V. Alapat, MD, Donghoon Yoon, PhD, Manoj Kumar, MD, Aasiya Matin, MD, Hongyun Zhu, MD, Cerisse Harcourt, APN, Maurizio Zangari, MD

Blood (2014) 124 (21): 2999.

https://doi.org/10.1182/blood.V124.21.2999.2999

Published: 2014

Journal Articles

Flow Cytometry Defined Cytoplasmic Immunoglobulin Index Is a Major Prognostic Factor for Progression of Asymptomatic Monoclonal Gammopathies to Clinical Multiple Myeloma

Xenofon Papanikolaou, MD, Adam Rosenthal, Rashid Z Khan, MD, Joshua Epstein, DSc, Christoph Heuck, MD, Madhav V. Dhodapkar, MD, Yogesh Jethava, MB, MRCP, MD FRCPath, Maurizio Zangari, MD, Omar Atiq, MD, Sarah Waheed, MD, Faith Davies, MD, Gareth J Morgan, MD PhD, Bart Barlogie, MD PhD

Blood (2014) 124 (21): 2079.

https://doi.org/10.1182/blood.V124.21.2079.2079

Published: 2014

Journal Articles

Investigation Of The Genetic Disparities Between African Americans and Causasians Utilizing Gene Expression Profiles (GEP) Of Purified Plasma Cells (PC) and Whole Bone Marrow Biopsies (BMBx)

Adam Rosenthal, Christoph Heuck, MD, Aziz Bakhous, M.D., Frits van Rhee, MD, PhD, Antje Hoering, PhD, Sarah Waheed, MD, Nathan M Petty, MS, Clyde Bailey, Donald Johann, MD, MS, Joshua Epstein, DSc, John Crowley, PhD, Bart Barlogie, MD, PhD

Blood (2013) 122 (21): 1870.

https://doi.org/10.1182/blood.V122.21.1870.1870

Published: 2013

Journal Articles

Final Results Of Phase II Study Of Pomalidomide (Pom) In GEP-Defined High Risk Relapsed and Refractory Multiple Myeloma (RRMM)

Saad Z Usmani, MD, FACP, Kelly Stratton, Emily Hansen, MS, Qing Zhang, PhD, Susan B. Panozzo, BS, Nathan M Petty, MS, Antje Hoering, Sarah Waheed, MD, Frits van Rhee, John Crowley, PhD, Bart Barlogie, MD

Blood (2013) 122 (21): 3191.

https://doi.org/10.1182/blood.V122.21.3191.3191

Published: 2013

Journal Articles

Cytogenetic Features Of Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS) and Asymptomatic Multiple Myeloma (AMM)

Erming Tian, PhD, Sarah Waheed, MD, Jeffrey Sawyer, PhD, Qing Zhang, PhD, Christoph Heuck, MD, Madhav V. Dhodapkar, MD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc

Blood (2013) 122 (21): 3108.

https://doi.org/10.1182/blood.V122.21.3108.3108

Published: 2013

Journal Articles

Non-Producing Multiple Myeloma (MM) Is a Distinct Subset Of Non-Secretory MM Characterized By High Cyclin D1 Expression and Decreased Progression Free Survival

Xenofon Papanikolaou, MD, Qing Zhang, PhD, Christoph Heuck, MD, Sarah Waheed, MD, Shebli Atrash, MD, Zeba N Singh, MD, Daisy V. Alapat, MD, Frits van Rhee, MD, PhD, Shweta S. Chavan, PhD, Joshua Epstein, DSc, Bart Barlogie, MD, PhD

Blood (2013) 122 (21): 1911.

https://doi.org/10.1182/blood.V122.21.1911.1911

Published: 2013

Journal Articles

Comparing Gene Expression Profiling (GEP) Features Of Bone Marrow Biopsies (BMBx) Of Patients With Multiple Myeloma (MM) and Normal Donors (NL): 24 Microenvironment Specific Gene Probes Distinguish MM From NL

Christoph Heuck, MD, Pingping Qu, PhD, Emily Hansen, MS, Qing Zhang, PhD, Adam Rosenthal, Frits van Rhee, MD, PhD, Sarah Waheed, MD, Shebli Atrash, MD, Purvi Patel, Antje Hoering, PhD, Joshua Epstein, John Crowley, PhD, Bart Barlogie, MD, PhD

Blood (2013) 122 (21): 1913.

https://doi.org/10.1182/blood.V122.21.1913.1913

Published: 2013

Journal Articles

Role Of Cytogenetic Abnormalities At Baseline and During 5-Year Follow-Up In Multiple Myeloma Patients Treated On The Total Therapy 3 Protocol

Sarah Waheed, MD, Jeffrey Sawyer, PhD, Adam Rosenthal, Frits van Rhee, MD, PhD, Nathan M Petty, MS, Saad Z Usmani, MD, FACP, Clyde Bailey, Christoph Heuck, MD, Antje Hoering, PhD, Bart Barlogie, MD, PhD

Blood (2013) 122 (21): 3137.

https://doi.org/10.1182/blood.V122.21.3137.3137

Published: 2013

Journal Articles

Intra-Tumoral Heterogeneity In Multiple Myeloma Gleaned From Gene Expression Profiling Analysis Of Plasma Cells and Bone Marrow Biopsies: Comparison Of Random Bone Marrow Samples and CT-Guided Fine Needle Aspirations Of MRI-Defined Focal Lesions

Bart Barlogie, MD, PhD, Emily Hansen, MS, Sarah Waheed, MD, Jameel Muzaffar, MD, Monica Grazziutti, MD, Donald Johann, MD, MS, Frits van Rhee, MD, PhD, Qing Zhang, PhD, Christoph Heuck, MD, Joshua Epstein, DSc

Blood (2013) 122 (21): 3123.

https://doi.org/10.1182/blood.V122.21.3123.3123

Published: 2013

Journal Articles

Five Gene Probes Carry Most Of The Discriminatory Power Of The 70-Gene Risk Model In Multiple Myeloma

Christoph Heuck, MD, Pingping Qu, PhD, Frits van Rhee, MD, PhD, Sarah Waheed, MD, Saad Z Usmani, MD, FACP, Joshua Epstein, DSc, Qing Zhang, PhD, Antje Hoering, John Crowley, PhD, Bart Barlogie, MD, PhD

Blood (2013) 122 (21): 125.

https://doi.org/10.1182/blood.V122.21.125.125

Published: 2013

Journal Articles

Total Therapy (TT) Studies For Gene Expression Profiling (GEP)-Defined High-Risk Multiple Myeloma

Christoph Heuck, MD, Frits van Rhee, MD, PhD, Alan Mitchell, Adam Rosenthal, Sarah Waheed, MD, Nathan M Petty, MS, Clyde Bailey, Ryan Williams, Ryan van Laar, PhD, Susan B. Panozzo, BS, Jeffrey Sawyer, PhD, John Crowley, PhD, Bart Barlogie, MD, PhD

Blood (2013) 122 (21): 126.

https://doi.org/10.1182/blood.V122.21.126.126

Published: 2013

NARROW

Assessment of Total Lesion Glycolysis and Metabolic Tumor Volume Improve the Clinical Value of Focal Lesion Assessment By FDG PET/CT in Myeloma

Re-Mineralization of Large Pelvic Lytic Lesions By CT Imaging in Patients with Multiple Myeloma: The Arkansas Experience

Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma

Spectrum of Cerebrovascular Disease in Multiple Myeloma Patients Undergoing Chemotherapy

Outcomes of Autologous Transplantation for Treatment-Related AML and MDS in Previously Treated Multiple Myeloma Patients (pts)

A Prognostic 51-Gene Signature Linked to Abnormal Metaphase Cytogenetics Identifies Myeloma Patients Who Benefit from Fractionated Melphalan Dosing and Added Bortezomib, Thalidomide and Dexamethasone As Conditioning for Autologous Stem Cell Transplant

Defining the Impact of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma: A Case-Match Analysis in the Total Therapy Trials

Comprehensive Genomic Profiling of Multiple Myeloma in the Course of Clinical Care Identifies Targetable and Prognostically Significant Genomic Alterations

The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM

Waldenstrom's Macroglobulinemia Associated Bone Disease the UAMS Experience

Flow Cytometry Defined Cytoplasmic Immunoglobulin Index Is a Major Prognostic Factor for Progression of Asymptomatic Monoclonal Gammopathies to Clinical Multiple Myeloma

Investigation Of The Genetic Disparities Between African Americans and Causasians Utilizing Gene Expression Profiles (GEP) Of Purified Plasma Cells (PC) and Whole Bone Marrow Biopsies (BMBx)

Final Results Of Phase II Study Of Pomalidomide (Pom) In GEP-Defined High Risk Relapsed and Refractory Multiple Myeloma (RRMM)

Cytogenetic Features Of Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS) and Asymptomatic Multiple Myeloma (AMM)

Non-Producing Multiple Myeloma (MM) Is a Distinct Subset Of Non-Secretory MM Characterized By High Cyclin D1 Expression and Decreased Progression Free Survival

Comparing Gene Expression Profiling (GEP) Features Of Bone Marrow Biopsies (BMBx) Of Patients With Multiple Myeloma (MM) and Normal Donors (NL): 24 Microenvironment Specific Gene Probes Distinguish MM From NL

Role Of Cytogenetic Abnormalities At Baseline and During 5-Year Follow-Up In Multiple Myeloma Patients Treated On The Total Therapy 3 Protocol

Intra-Tumoral Heterogeneity In Multiple Myeloma Gleaned From Gene Expression Profiling Analysis Of Plasma Cells and Bone Marrow Biopsies: Comparison Of Random Bone Marrow Samples and CT-Guided Fine Needle Aspirations Of MRI-Defined Focal Lesions

Five Gene Probes Carry Most Of The Discriminatory Power Of The 70-Gene Risk Model In Multiple Myeloma

Total Therapy (TT) Studies For Gene Expression Profiling (GEP)-Defined High-Risk Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only